U.S. market Closed. Opens in 1 day 9 hours 26 minutes

SELB | Selecta Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
RevenueN/A110.78M85.08M16.60M6.68M903.00K207.00K8.08M6.01M3.04M
Cost of RevenueN/A72.38M68.74M54.51M42.74MN/AN/AN/AN/AN/A
Gross ProfitN/A38.40M16.34M-37.91M-36.07M903.00KN/AN/AN/AN/A
Operating Expenses112.42M96.24M89.67M73.42M59.13M65.92M63.99M42.75MN/AN/A
Selling, General & Admin40.58M23.86M20.94M18.91M16.39M18.24M18.83M13.05M8.34M7.95M
Research & Development71.84M72.38M68.74M54.51M42.74M47.69M45.16M29.70M22.98M10.49M
Other Operating ExpensesN/A330.00K15.00K89.00K-1.31M10.00KN/AN/AN/AN/A
Operating Income-86.42M14.54M-4.60M-56.82M-52.45M-65.02M-63.78M-34.67M-25.30M-15.40M
Other Expenses / Income-152.29M20.23M-5.12M-12.05M-2.90M1.18M-1.54M-1.54M130.00K2.52M
Before Tax Income-238.71M34.77M-9.72M-68.88M-55.35M-65.34M-65.32M-36.21M-25.17M-12.88M
Income Tax Expenses19.00M-609.00K15.97M911.00K-1.81M1.18MN/AN/AN/AN/A
Net Income-219.71M35.38M-25.69M-69.79M-53.54M-65.34M-65.32M-36.21M-25.17M-12.88M
Interest Expenses-2.83M3.03M2.84M1.56M1.52M1.49M1.21M1.25M948.00K552.00K
Basic Shares Outstanding155.11B144.76M114.33M101.20M45.55M22.39M20.43M10.49M10.06M12.87M
Diluted Shares Outstanding155.11B145.87M114.33M101.20M45.55M22.39M20.43M10.49M10.06M12.87M
EBITDA-86.42M16.16M-4.58M-56.73M-53.76M-65.01M-63.37M-34.16M-23.18M-11.46M
EBITDA Margin0.00%14.58%-5.39%-341.82%-805.17%-7,199.56%-30,611.11%-422.55%-385.66%-377.11%
EBIT-203.54M37.80M-6.88M-67.32M-53.83M-62.66M-64.11M-34.96M-24.23M-12.33M
EBIT Margin0.00%34.12%-8.08%-405.62%-806.22%-6,939.31%-30,973.43%-432.48%-403.03%-405.53%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙